Literature DB >> 29695463

Population-Based Assessment of the Long-Term Risk of Seizures in Survivors of Stroke.

Alexander E Merkler1,2, Gino Gialdini3, Michael P Lerario3,2,4, Neal S Parikh3,5, Nicholas A Morris6, Benjamin Kummer3,2,5, Lauren Dunn5, Michael E Reznik3,2,5, Santosh B Murthy3,2, Babak B Navi3,2, Zachary M Grinspan7,8, Costantino Iadecola3,2, Hooman Kamel3,2.   

Abstract

BACKGROUND AND
PURPOSE: We sought to determine the long-term risk of seizures after stroke according to age, sex, race, and stroke subtype.
METHODS: We performed a retrospective cohort study using administrative claims from 2 complementary patient data sets. First, we analyzed data from all emergency department visits and hospitalizations in California, Florida, and New York from 2005 to 2013. Second, we evaluated inpatient and outpatient claims from a nationally representative 5% random sample of Medicare beneficiaries. Our cohort consisted of all adults at the time of acute stroke hospitalization without a prior history of seizures. Our outcome was seizure occurring after hospital discharge for stroke. Poisson regression and demographic data were used to calculate age-, sex-, and race-standardized incidence rate ratios (IRR).
RESULTS: Among 777 276 patients in the multistate cohort, the annual incidence of seizures was 1.68% (95% confidence interval [CI], 1.67%-1.70%) after stroke versus 0.15% (95% CI, 0.15%-0.15%) among the general population (IRR, 7.3; 95% CI, 7.3-7.4). By 8 years, the cumulative rate of any emergency department visit or hospitalization for seizure was 9.27% (95% CI, 9.16%-9.38%) after stroke versus 1.21% (95% CI, 1.21%-1.22%) in the general population. Stroke was more strongly associated with a subsequent seizure among patients <65 years of age (IRR, 12.0; 95% CI, 11.9-12.2) than in patients ≥65 years of age (IRR, 5.5; 95% CI, 5.4-5.5) and in the multistate analysis, the association between stroke and seizure was stronger among nonwhite patients (IRR, 11.0; 95% CI, 10.8-11.2) than among white patients (IRR, 7.3; 95% CI, 7.2-7.4). Risks were especially elevated after intracerebral hemorrhage (IRR, 13.3; 95% CI, 13.0-13.6) and subarachnoid hemorrhage (IRR, 13.2; 95% CI, 12.8-13.7). Our study of Medicare beneficiaries confirmed these findings.
CONCLUSIONS: Almost 10% of patients with stroke will develop seizures within a decade. Hemorrhagic stroke, nonwhite race, and younger age seem to confer the greatest risk of developing seizures.
© 2018 American Heart Association, Inc.

Entities:  

Keywords:  Medicare; incidence; seizures; stroke; survivors

Mesh:

Year:  2018        PMID: 29695463      PMCID: PMC6093303          DOI: 10.1161/STROKEAHA.117.020178

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  27 in total

1.  The pooled incidence of post-stroke seizure in 102 008 patients.

Authors:  Safeng Zou; Xiaomei Wu; Bo Zhu; Jinyang Yu; Bowen Yang; Jingpu Shi
Journal:  Top Stroke Rehabil       Date:  2015-04-28       Impact factor: 2.119

2.  Epilepsy after aneurysmal subarachnoid hemorrhage: A population-based, long-term follow-up study.

Authors:  Jukka Huttunen; Mitja I Kurki; Mikael von Und Zu Fraunberg; Timo Koivisto; Antti Ronkainen; Jaakko Rinne; Juha E Jääskeläinen; Reetta Kälviäinen; Arto Immonen
Journal:  Neurology       Date:  2015-05-06       Impact factor: 9.910

3.  Epileptic seizures after a first stroke: the Oxfordshire Community Stroke Project.

Authors:  J Burn; M Dennis; J Bamford; P Sandercock; D Wade; C Warlow
Journal:  BMJ       Date:  1997-12-13

4.  Onset seizures independently predict poor outcome after subarachnoid hemorrhage.

Authors:  H Butzkueven; A H Evans; A Pitman; C Leopold; D J Jolley; A H Kaye; C J Kilpatrick; S M Davis
Journal:  Neurology       Date:  2000-11-14       Impact factor: 9.910

5.  Delayed seizures after intracerebral haemorrhage.

Authors:  Alessandro Biffi; Abbas Rattani; Christopher D Anderson; Alison M Ayres; Edip M Gurol; Steven M Greenberg; Jonathan Rosand; Anand Viswanathan
Journal:  Brain       Date:  2016-08-06       Impact factor: 13.501

6.  Validating administrative data in stroke research.

Authors:  David L Tirschwell; W T Longstreth
Journal:  Stroke       Date:  2002-10       Impact factor: 7.914

7.  Long-term outcomes following development of new-onset atrial fibrillation during sepsis.

Authors:  Allan J Walkey; Bradley G Hammill; Lesley H Curtis; Emelia J Benjamin
Journal:  Chest       Date:  2014-11       Impact factor: 9.410

8.  The validity of epilepsy or seizure documentation in nursing homes.

Authors:  Nancy A Hardie; Judith Garrard; Cynthia R Gross; Sandra E Bowers; John O Rarick; Patricia Bland; Ilo E Leppik
Journal:  Epilepsy Res       Date:  2007-04-19       Impact factor: 3.045

9.  Population-based study of seizure disorders after cerebral infarction.

Authors:  E L So; J F Annegers; W A Hauser; P C O'Brien; J P Whisnant
Journal:  Neurology       Date:  1996-02       Impact factor: 9.910

10.  Incidence and associations of poststroke epilepsy: the prospective South London Stroke Register.

Authors:  Neil S N Graham; Siobhan Crichton; Michael Koutroumanidis; Charles D A Wolfe; Anthony G Rudd
Journal:  Stroke       Date:  2013-01-31       Impact factor: 7.914

View more
  10 in total

1.  Medicare claims can identify post-stroke epilepsy.

Authors:  Lidia M V R Moura; Jason R Smith; Deborah Blacker; Christine Vogeli; Lee H Schwamm; John Hsu
Journal:  Epilepsy Res       Date:  2019-02-08       Impact factor: 3.045

2.  Poststroke Seizures and the Risk of Dementia Among Young Stroke Survivors.

Authors:  Alain Lekoubou; Djibril M Ba; Clever Nguyen; Guodong Liu; Douglas L Leslie; Leonardo Bonilha; Chinchilli M Vernon
Journal:  Neurology       Date:  2022-05-18       Impact factor: 11.800

3.  Association Between IL-6 and Seizure Recurrence in Patients with the First Post-Ischemic Stroke Seizure.

Authors:  Qi Jia; Fan Jiang; Daliang Ma; Jun Li; Fan Wang; Zhiqiang Wang
Journal:  Neuropsychiatr Dis Treat       Date:  2020-08-11       Impact factor: 2.570

Review 4.  Late epileptic seizures following cerebral venous thrombosis: a systematic review and meta-analysis.

Authors:  Sara Gasparini; Sabrina Neri; Francesco Brigo; Vittoria Cianci; Anna Mammì; Angelo Pascarella; Lucia Manzo; Paolo Benna; Pasquale Striano; Tommaso Martino; Michele Romoli; Lorenzo Muccioli; Annacarmen Nilo; Mariarosaria Valente; Claudia Cagnetti; Angelo Labate; Antonio Gambardella; Francesco Pisani; Sara Casciato; Giancarlo Di Gennaro; Vincenzo Belcastro; Umberto Aguglia; Edoardo Ferlazzo
Journal:  Neurol Sci       Date:  2022-05-31       Impact factor: 3.830

5.  [Epilepsy in old age].

Authors:  Kai Siebenbrodt; Adam Strzelczyk; Felix Rosenow
Journal:  Nervenarzt       Date:  2020-04       Impact factor: 1.214

6.  Glibenclamide, a Sur1-Trpm4 antagonist, does not improve outcome after collagenase-induced intracerebral hemorrhage.

Authors:  Cassandra M Wilkinson; Paul S Brar; Celine J Balay; Frederick Colbourne
Journal:  PLoS One       Date:  2019-05-01       Impact factor: 3.240

7.  Failure of bumetanide to improve outcome after intracerebral hemorrhage in rat.

Authors:  Cassandra M Wilkinson; Brittany A Fedor; Jasmine R Aziz; Colby A Nadeau; Paul S Brar; Julia J A Clark; Frederick Colbourne
Journal:  PLoS One       Date:  2019-01-10       Impact factor: 3.240

8.  Predictive Factors for Early-Onset Seizures in Patients With Cerebral Venous Sinus Thrombosis.

Authors:  Shuwen Mu; Jun Li; Kunzhe Lin; Yi Fang; Feng Lin; Ziqi Li; Yongjun Xu; Shousen Wang
Journal:  Front Neurol       Date:  2022-03-29       Impact factor: 4.003

9.  Smoking-cessation pharmacotherapy for patients with stroke and TIA: Systematic review.

Authors:  Neal S Parikh; Setareh Salehi Omran; Hooman Kamel; Mitchell S V Elkind; Joshua Z Willey
Journal:  J Clin Neurosci       Date:  2020-04-22       Impact factor: 1.961

10.  Anticonvulsant Primary and Secondary Prophylaxis for Acute Ischemic Stroke Patients: A Decision Analysis.

Authors:  Michael B Westover; Lidia M V R Moura; Felipe J S Jones; Paula R Sanches; Jason R Smith; Sahar F Zafar; Sonia Hernandez-Diaz; Deborah Blacker; John Hsu; Lee H Schwamm
Journal:  Stroke       Date:  2021-06-15       Impact factor: 10.170

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.